- Simulations Plus and the University of Connecticut Receive New FDA Grant to Expand Mechanistic Modeling Approaches for Long-Acting Injectables (11/13/2024)
- Simulations Plus and Partners Awarded New FDA Grant to Validate In Vitro-In Vivo Extrapolation Methods for Complex Formulations (10/30/2024)
- Simulations Plus and the University of Southern California Secure NIH Grant to Develop New AI Drug Discovery Offerings (10/08/2024)
- Simulations Plus Announces New Research Project with the International Collaboration on Cosmetics Safety (07/11/2024)
- InnoGI Technologies and Simulations Plus Combine Forces to Offer Next-Level Modeling Solutions for the Prediction of Oral Drug Performance (04/17/2024)
- U.S. FDA Renews DILIsym® Software Licenses for 7th Year (04/04/2024)
- Simulations Plus and the University of Bath Awarded New FDA Grant (03/05/2024)
- Simulations Plus Hosts MIDD+ Cambridge UK (02/29/2024)
- Simulations Plus Extends Collaboration with Major Toxicology Research Agency (02/15/2024)
- Simulations Plus Embarks on Collaboration with Northeastern University and The TIM Company Through New FDA Grant (01/09/2024)